Tag results:
GLI1
Mammary Cell News
Aberrant Super-Enhancer-Driven Oncogene ENC1 Promotes the Radio-Resistance of Breast Carcinoma
[Cell Death & Disease] ENC1-SEdistal deletion reduced ENC1 expression and inhibited the malignant behavior of breast carcinoma cells and their resistance to radiotherapy.
Prostate Cell News
MiR-367-3p Downregulates Rab23 Expression and Inhibits Hedgehog Signaling Resulting in the Inhibition of the Proliferation, Migration, and Invasion of Prostate Cancer Cells
[Oncology Reports] Investigators investigated the inhibitory effect of miR‑367‑3p on the proliferation, invasion, and metastasis of prostate cancer cells.
Mesenchymal Cell News
Localized Chondro-Ossification Underlies Joint Dysfunction and Motor Deficits in the Fkbp10 Mouse Model of Osteogenesis Imperfecta
[Proceedings of the National Academy of Sciences of the United States of America] The pathogenic mechanisms underlying joint dysfunction in osteogenesis imperfecta are poorly understood. The authors generated a mouse model in which Fkbp10 was conditionally deleted in tendons and ligaments.
Cancer Stem Cell News
ETV4 Promotes Breast Cancer Cell Stemness by Activating Glycolysis and CXCR4-Mediated Sonic Hedgehog Signaling
[Cell Death Discovery] Regulation of cancer cell metabolism rewiring and stemness is not completely understood. Scientists reported that ETV4 is a key transcription factor in regulating glycolytic gene expression.
Cancer Stem Cell News
Aspartame Induces Cancer Stem Cell Enrichment through p21, NICD and GLI1 in Human PANC-1 Pancreas Adenocarcinoma Cells
[Food and Chemical Toxicology] Researchers indicated that a high level of glucose exposure does not effect the invasion and migration of PANC-1 cells, while aspartame increases both of these aggressiveness criterias.
Dermal Cell News
Targeting Non-Canonical Activation of GLI1 by the SOX2-BRD4 Transcriptional Complex Improves the Efficacy of HEDGEHOG Pathway Inhibition in Melanoma
[Oncogene] Researchers identified a novel SOX2-BRD4 transcriptional complex driving the expression of GLI1, the final effector of the Hedgehog/GLI (HH/GLI) pathway, providing a novel mechanism of non-canonical Smoothened-independent activation of HH/GLI signaling in melanoma.